An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing
As the COVID-19 pandemic continues, variants of the virus are emerging. Here the authors present a diagnostic assay that can detect wildtype and known variants using engineered Cas12a.
Guardado en:
Autores principales: | Kean Hean Ooi, Mengying Mandy Liu, Jie Wen Douglas Tay, Seok Yee Teo, Pornchai Kaewsapsak, Shengyang Jin, Chun Kiat Lee, Jingwen Hou, Sebastian Maurer-Stroh, Weisi Lin, Benedict Yan, Gabriel Yan, Yong-Gui Gao, Meng How Tan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/caf7de7ec01a4742a1eed676b48f380b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Harnessing CRISPR-Cas to Combat COVID-19: From Diagnostics to Therapeutics
por: Kok Gan Chan, et al.
Publicado: (2021) -
Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair
por: Mollie S. Schubert, et al.
Publicado: (2021) -
Bacterial resistance to CRISPR-Cas antimicrobials
por: Ruben V. Uribe, et al.
Publicado: (2021) -
Applications of CRISPR-Cas Technologies to Proteomics
por: Georgii Dolgalev, et al.
Publicado: (2021) -
CRISPR/Cas9 in Gastrointestinal Malignancies
por: André Jefremow, et al.
Publicado: (2021)